Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Desai

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|October 20, 2010
Response assessment in gastrointestinal stromal tumorJayesh Desai
Current Treatment Options in Oncology|October 24, 2002
Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitorsSuzanne George, Jayesh Desai
ESMO Open|September 16, 2020
New biomarkers for checkpoint inhibitor therapyNikki Burdett, Jayesh Desai
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2013
Personalized management: inoperable gastrointestinal stromal tumorsSusie Bae, Jayesh Desai
Targeted Oncology|August 15, 2014
Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategiesJeanne Tie, Jayesh Desai
Critical Reviews in Oncogenesis|April 5, 2012
Antiangiogenic therapies targeting the vascular endothelia growth factor signaling systemJeanne Tie, Jayesh Desai
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcomaChristopher W Ryan, Jayesh Desai
Expert Review of Anticancer Therapy|May 25, 2018
Nivolumab for the treatment of colorectal cancerKortnye Maureen Smith, Jayesh Desai
Best Practice & Research. Clinical Haematology|March 29, 2005
Recombinant human erythropoietin in cancer-related anemia: an evidence-based reviewJayesh Desai, George D Demetri
Current Cancer Drug Targets|September 11, 2008
Clinical use of therapies targeting tumor vasculature and stromaIan D Davis, Jayesh Desai
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|October 20, 2010
Response assessment in gastrointestinal stromal tumorJayesh Desai
Current Treatment Options in Oncology|October 24, 2002
Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitorsSuzanne George, Jayesh Desai
ESMO Open|September 16, 2020
New biomarkers for checkpoint inhibitor therapyNikki Burdett, Jayesh Desai
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2013
Personalized management: inoperable gastrointestinal stromal tumorsSusie Bae, Jayesh Desai
Targeted Oncology|August 15, 2014
Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategiesJeanne Tie, Jayesh Desai
Critical Reviews in Oncogenesis|April 5, 2012
Antiangiogenic therapies targeting the vascular endothelia growth factor signaling systemJeanne Tie, Jayesh Desai
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcomaChristopher W Ryan, Jayesh Desai
Expert Review of Anticancer Therapy|May 25, 2018
Nivolumab for the treatment of colorectal cancerKortnye Maureen Smith, Jayesh Desai
Best Practice & Research. Clinical Haematology|March 29, 2005
Recombinant human erythropoietin in cancer-related anemia: an evidence-based reviewJayesh Desai, George D Demetri
Current Cancer Drug Targets|September 11, 2008
Clinical use of therapies targeting tumor vasculature and stromaIan D Davis, Jayesh Desai
Pageof 18